US Patent 7511154 Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts

Patent 7511154 was granted and assigned to Basilea Pharmaceutica on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Basilea Pharmaceutica

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7511154

Date of Patent

March 31, 2009

Patent Application Number

11881487

Date Filed

July 26, 2007

Patent Primary Examiner

‌

Golam M. Shameem

Patent abstract

A process for producing the compound (1′benzyl-2-oxo-[1,3′]-(R)-bipyrrolidinyl-3-(R,S)-yl)-triphenyl-phosphonium bromide which is an intermediate for antibacterial vinylpyrrolidinone-cephalosporin derivatives.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7511154 Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API